5th Dec 2007 08:00
Consort Medical PLC05 December 2007 Consort Medical plc Board Changes Consort Medical plc is pleased to announce the appointment of Jon Glenn as ChiefExecutive. Jon who is currently Finance Director of the Company will take up theappointment with immediate effect. Mark Throdahl is leaving the Group today after six years in the role. Current trading continues to be in line with the expectations set out in thetrading update issued on 22 November and the Company will announce interimresults for the period to 27 October on Wednesday 12 December 2007. Commenting on the Board changes, the Chairman, John Robinson, said "Jon has done an excellent job as Finance Director and the Board is delighted toappoint him as CEO. He has a first class knowledge of the Company and theleadership skills to take Consort Medical successfully into the future. I lookforward to working with Jon to deliver the Company's full potential. "Mark has led the Company successfully for over six years, building it into afocused leader in medical devices for inhaled drug delivery and anaesthesia andI would like to thank him for his contributions. He leaves the company in a verysound state and we wish him every success for the future." Paul Boughton, an executive director and qualified chartered accountant, will beacting Finance Director until an external appointment is made. A search hasbegun. Ends Consort MedicalJohn Robinson, Chairman Tel: +44 (0)1908 552600 MaitlandLiz Morley/Brian Hudspith Tel: +44 (0)20 7379 5151 Consort Medical is a leader in medical devices for inhaled drug delivery andanaesthesia. The Group develops drug delivery systems for the pharmaceuticalindustry and disposable airway management products for critical care settings inhospitals and emergency medicine. Consort Medical develops and manufactures metered dose inhaler valves,actuators, compliance aids, dry powder devices, disposable facemasks andcircuits, laryngeal tubes, and emergency medicine breathing equipment. The Grouphas facilities in King's Lynn and Milton Keynes in the UK, Indianapolis, Indianaand Kent, Ohio in the US, and Mumbai, India. Consort Medical is a public companyquoted on the full list of the London Stock Exchange (LSE: CSRT). Jonathan (Jon) Glenn (39) was appointed Group Finance Director, on 11 September2006. From 1998 to 2005 Jon Glenn was Global Head of Finance of Celltech Group plc.Following the sale of Celltech to UCB, in March 2005 he became Chief FinancialOfficer of Akubio, a Cambridge-based, private equity owned, developer ofinstrumentation for the life sciences industry. At Akubio Jon's responsibilitieshave included Finance, Investor Relations, IT and Legal. He is a member of theInstitute of Chartered Accountants in England and Wales. Jon Glenn has advised that, in accordance with paragraph 9.6.13 (2) - (6) of theListing Rules, he has no details to disclose. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CSRT.L